Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5713628 | American Journal of Otolaryngology | 2017 | 18 Pages |
Abstract
Patients who have a history of chemotherapy, immunosuppression, or recent hospital exposure prior to their surgery are at higher risk of developing MRSA-specific SSI and may benefit from prophylactic antibiotic therapy with appropriate coverage. Additionally, patients who develop MRSA SSIs are likely to have an extended postoperative inpatient stay.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Sharon Lin, Sami Melki, Michelle V. Lisgaris, Emily N. Ahadizadeh, Chad A. Zender,